Share This Page
Drug Price Trends for DOCUSATE SODIUM MINI ENEMA
✉ Email this page to a colleague
Average Pharmacy Cost for DOCUSATE SODIUM MINI ENEMA
| Drug Name | NDC | Price/Unit ($) | Unit | Date |
|---|---|---|---|---|
| DOCUSATE SODIUM MINI ENEMA | 00904-6920-93 | 0.47540 | ML | 2025-12-17 |
| DOCUSATE SODIUM MINI ENEMA | 00904-6920-93 | 0.47540 | ML | 2025-11-19 |
| DOCUSATE SODIUM MINI ENEMA | 00904-6920-93 | 0.47980 | ML | 2025-10-22 |
| DOCUSATE SODIUM MINI ENEMA | 00904-6920-93 | 0.48767 | ML | 2025-09-17 |
| >Drug Name | >NDC | >Price/Unit ($) | >Unit | >Date |
DOCUSATE SODIUM MINI ENEMA Market Analysis and Financial Projection
Market Analysis and Price Projections for Docusate Sodium Mini Enema
Market Overview
Docusate sodium mini enema is a pediatric laxative used to treat occasional constipation. It is administered rectally in a small-volume enema form, typically 15-30 mL. Market demand stems from pediatric healthcare settings, home care, and long-term care facilities. The product's market size is influenced by aging populations, the prevalence of constipation, and physician prescribing habits.
The global laxatives market was valued at approximately $3.2 billion in 2022, with the enema segment accounting for about 15%, driven mainly by chronic constipation and bowel management programs. Docusate-based products are among the top prescribed stool softeners due to their safety profile.
Key Market Drivers
- Increased aging populations leading to higher constipation prevalence in adults.
- Rising pediatric health awareness and parental demand for safe, non-invasive bowel management.
- Growing home healthcare utilization.
- Patent expirations or availability of generic formulations reduce costs and expand accessibility.
Competitive Landscape
Major players include Sigma-Aldrich (now part of MilliporeSigma), Perrigo, and Teva Pharmaceuticals, which offer various formulations, including rectal enemas. The patent landscape for docusate enema formulations is limited, with most formulations off patent, increasing generic competition. However, the mini enema form factor distinguishes specific products.
Regulatory Environment
In the U.S., marketed as an OTC drug under the FDA’s monograph for laxatives. Pediatric indications require compliance with safety guidelines, including proper dosing and packaging. The European market follows EMA regulations, with several approvals for OTC pediatric laxatives.
Price Projections
Current retail prices for generic docusate sodium mini enema products range from $0.50 to $1.50 per 15 mL unit, with variations based on branding, packaging, and purchasing volume.
| Year | Estimated Price (per 15 mL unit) | Notes |
|---|---|---|
| 2023 | $0.80 - $1.20 | Average retail price for generic and branded products |
| 2025 | $0.75 - $1.10 | Slight decline due to increased generic competition |
| 2030 | $0.70 - $1.00 | Continued price erosion expected |
The downward trend reflects market penetration of generics and increased manufacturing efficiency. Price sensitivity among consumers and payers, especially in OTC categories, maintains pressure on prices.
Future Market Dynamics
- Product innovation: Smaller, unit-dose packages or pre-filled applicators could command premium prices.
- Formulation improvements: Enhanced safety or ease of use may increase adoption.
- Regulatory changes: Expansion of pediatric indications could expand the market size.
- Reimbursement policies: Insurance coverage for OTC products remains limited, keeping prices consumer-driven.
Investment Considerations
Manufacturers seeking market entry should focus on regulatory compliance, pediatric safety data, and differentiated packaging. Cost-efficient manufacturing and strategic partnerships are key to competitive pricing.
Key Takeaways
- The global laxative market is growing with increased demand in pediatric and elderly populations.
- Docusate sodium mini enema prices today range between $0.50 and $1.50 per unit, with potential slight declines driven by generics.
- Market growth potential hinges on product innovation, regulatory approvals for new indications, and manufacturing efficiencies.
- Competitive landscape favors companies with established OTC channels and strong brand recognition.
- Price erosion is expected to continue, emphasizing the importance of cost management and differentiation.
Frequently Asked Questions
1. What are the primary uses of docusate sodium mini enema?
Treatment of occasional constipation, primarily in pediatric patients and as part of bowel management in healthcare settings.
2. How does the mini enema format differ from other docusate formulations?
It provides a small-volume, rectally administered dose, suitable for children and ease of use compared to larger volume or oral options.
3. What factors influence the pricing of docusate sodium mini enema products?
Generic competition, packaging, branding, distribution costs, and market demand.
4. Are there any regulatory challenges for new mini enema products?
Yes, especially regarding pediatric safety data and obtaining OTC approval from agencies such as FDA and EMA.
5. What is the outlook for innovation in this market segment?
Focus areas include pre-filled applicators, improved safety profiles, and formulations tailored for specific age groups.
References
- MarketWatch, "Global Laxatives Market Size, Share & Trends," 2022.
- FDA, OTC Drug Review Data, 2023.
- European Medicines Agency, Pediatric Laxatives Approvals, 2023.
- IQVIA, Market Data and Pricing Trends, 2022-2023.
- Global Industry Analysts, "Constipation and Bowel Management Market," 2022.
More… ↓
